Additionally, studies suggest that glutaminase and mTOR inhibition causes GBM cell death and tumor inhibition in a xenograft model, resulting in an increased intracellular glutamate level and upregulation of glutaminase in GBM U87MG, and to a greater extent in U87/EGFRvIII cells [34]. Here, MTOR is linked to glioblastoma.